Atlas Trials

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Clinical trial NCT04499118 · UNKNOWN

Trial details

NCT number
NCT04499118
Sponsor
Sichuan Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
HER2-negative Breast Cancer
Start date
2020-08-01
Primary completion
2021-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.